Cotización Entero Therapeutics - ENTO

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

0.53

Postura de Compra

0.52

Postura de Venta

0.53

Volume Operado de la Acción

68,931

0.4802 Rango del Día 0.52215

0.185 Rango de 52 semanas 3.16

Precio Anterior

0.50

Precio de Apertura

0.4802

Hora

0.53

Última hora de negociación

Volumen promedio (3 m)

208,157

Volumen financiero

US$ 34,174

Precio Promedio Ponderado

0.495774

Form 8-K - Current report

Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum

BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Proposed merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing (i) Journey’s next-gen, first-in-class ADC-rivalling, nano-immunoconjugates (“NIC”) platform...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0.0296	5.91526778577	0.5004	0.537899	0.45	91053	0.50150347	CS
4	-0.1	-15.873015873	0.63	0.7	0.3612	71341	0.56141382	CS
12	-0.17	-24.2857142857	0.7	0.926	0.3612	208157	0.66264502	CS
26	-0.1893	-26.3172528847	0.7193	0.926	0.185	511991	0.45072218	CS
52	-2.43	-82.0945945946	2.96	3.16	0.185	396597	0.50343947	CS
156	-2.43	-82.0945945946	2.96	3.16	0.185	396597	0.50343947	CS
260	-2.43	-82.0945945946	2.96	3.16	0.185	396597	0.50343947	CS

ENTO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Entero Therapeutics?

El precio actual de las acciones de Entero Therapeutics es US$ 0.53

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Entero Therapeutics?

Entero Therapeutics ha negociado en un rango de US$ 0.185 a US$ 3.16 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
FOXXFoxx Development Holdings Inc	US$ 6.355 (119.90%)	33.52M
BHILBenson Hill Inc	US$ 3.925 (118.06%)	13.52M
TECXTectonic Therapeutic Inc	US$ 55.18 (114.54%)	5.46M
AMODAlpha Modus Holdings Inc	US$ 3.2299 (109.73%)	125.47M
DOMHDominari Holdings Inc	US$ 3.61 (59.03%)	4.24M
CLEUChina Liberal Education Holdings Ltd	US$ 0.149 (-98.08%)	311.38M
CRGXCARGO Therapeutics Inc	US$ 3.39 (-74.30%)	21.21M
TDTHTrident Digital Tech Holdings Ltd	US$ 1.0159 (-58.87%)	2.46M
EVTVEnvirotech Vehicles Inc	US$ 0.338202 (-49.30%)	4.78M
IRWDIronwood Pharmaceuticals Inc	US$ 2.29 (-38.44%)	10.53M
NVDANVIDIA Corporation	US$ 124.65 (0.77%)	392.11M
CLEUChina Liberal Education Holdings Ltd	US$ 0.149 (-98.08%)	311.38M
MGOLMGO Global Inc	US$ 0.1199 (17.90%)	166.88M
SPGCSacks Parente Golf Inc	US$ 0.93 (57.63%)	129.08M
RIMEAlgorhythm Holdings Inc	US$ 0.02465 (-5.19%)	126.09M